Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (2378)	9/16/2008 10:17:41 AM
From: Jibacoa	Respond to of 3722

Better wait until it can close above $9 <g> bigcharts.marketwatch.com Maybe the presentation on Wed next week at the 2008 UBS Global Life Sciences Conference in N.Y. will help. Bernard

To: ~digs who wrote (2378)	10/3/2008 1:05:45 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

VASC is trying to rally from the $7 level. Although the more important support is at the $6 level, it is probably OK to start a position at this level with a tight stop loss at $6.90 bigcharts.marketwatch.com VASC has 4 Qs of better revenues and earnings have also been better in the last 3Qs. The pending results for the 3rdQ (Sep) should show a favorable comparison, since that was the Q in which the earnings faltered last Yr.( the EE for the Q are around $0.06 vs the $0.02 last Yr.) However, take into account that in the first 2Qs earnings are ahead $0.02 and for the full Yr. the EE don't show any significant improvement. It is in 2009 when the EE are around $0.33/shr that would be a 120% improvement from the 2008 EEs.<g> Also keep in mind that if the earnings in 2009 come out as expected, VASC's PE will still be about 3x the SPE's. And as previously mentioned, the important resistance is still at the $9 level. bigcharts.marketwatch.com RAGL Bernard